LongBio Pharma (Suzhou) Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by LongBio Pharma (Suzhou) Co., Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -27.87% vs -40.74% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-166.80",
          "val2": "-110.70",
          "chgp": "-50.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.30",
          "val2": "33.60",
          "chgp": "-45.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.30",
          "val2": "0.50",
          "chgp": "160.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-190.40",
          "val2": "-148.90",
          "chgp": "-27.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

0.00

Operating Profit (PBDIT) excl Other Income

-166.80

-110.70

-50.68%

Interest

18.30

33.60

-45.54%

Exceptional Items

1.30

0.50

160.00%

Consolidate Net Profit

-190.40

-148.90

-27.87%

Operating Profit Margin (Excl OI)

0.00%

0.00%

NA

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -27.87% vs -40.74% in Dec 2024

All Annual Results